Date published: 2026-5-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

3pK Inhibitors

The chemical class of 3pK inhibitors includes a range of compounds that indirectly modulate the activity of 3pK, primarily through their influence on various signaling pathways and kinases associated with 3pK's function. These inhibitors do not target 3pK directly but affect the cellular mechanisms and pathways crucial for its role in the MAPK/ERK signaling and related kinase activities. The primary mechanism of action for these inhibitors is the alteration of upstream kinases and signaling pathways that indirectly influence the activity of 3pK. Compounds such as U0126, PD98059, and SB203580 target MEK and p38 MAPK, respectively, key components of the MAPK/ERK pathway, which is closely linked to the function of 3pK. By inhibiting these kinases, they alter the activation and functioning of 3pK. Other inhibitors, like SP600125 and LY294002, target JNK and PI3K/AKT pathways, respectively, which can indirectly influence 3pK activity due to the interconnected nature of cellular signaling networks. Broad-spectrum kinase inhibitors such as Sorafenib, Sunitinib, and Dasatinib target multiple kinases and might affect 3pK through their wide-ranging effects on related signaling pathways. EGFR inhibitors like Gefitinib and Erlotinib also contribute to this modulation through their impact on EGFR signaling, which can have downstream effects on 3pK.

Items 1 to 10 of 14 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Hemacolor, Eosin

sc-396601
4 L
$143.00
(0)

Hemacolor, Eosin, as a 3pK, exhibits unique properties through its ability to form strong hydrogen bonds with polar solvents, enhancing its solubility and reactivity. Its distinct electron-withdrawing groups facilitate rapid electrophilic reactions, making it a potent dye in various chemical environments. The compound's vibrant color arises from its conjugated system, which allows for effective light absorption and distinct spectral characteristics, influencing its interaction with biological macromolecules.

MK-2 Inhibitor III

1186648-22-5sc-221948
5 mg
$400.00
3
(1)

MK-2 Inhibitor III, as a 3pK, showcases remarkable reactivity due to its ability to engage in specific π-π stacking interactions with aromatic systems, enhancing its stability in complex environments. Its unique functional groups promote selective nucleophilic attack, leading to distinct reaction pathways. The compound's hydrophobic regions contribute to its partitioning behavior, influencing its interactions with lipid membranes and altering its kinetic profile in various chemical contexts.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

An MEK inhibitor, potentially affecting MAPK/ERK signaling and thereby influencing 3pK activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Another MEK inhibitor, might impact MAPK/ERK pathway, indirectly affecting 3pK.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAPK, could indirectly influence 3pK activity through MAPK pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor, potentially affecting signaling pathways that involve 3pK.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor, might indirectly impact 3pK through PI3K/AKT signaling pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor, could influence 3pK activity by affecting mTOR signaling pathways.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

A multi-kinase inhibitor, potentially impacting 3pK by targeting related kinases.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Another multi-kinase inhibitor, might influence 3pK through its action on related kinases.